Advanced Micro Devices, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

Financial Instruments (Tables)

9 Months Ended

Sep. 26, 2015

Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract]

Summary of Available-for-sale Securities



	Total Fair Value		Cash and Cash Equivalents
	(In millions)
September 26, 2015
Cash	$	370	$	370
Level 2^{(2) (3)}
Commercial paper	385		385
Total level 2	385		385
Total	$	755	$	755



	Total Fair Value		Cash and Cash Equivalents		Short-Term Marketable Securities
	(In millions)
December 27, 2014
Cash	$	391	$	391	$	—
Level 1^{(1) (2)}
Money market funds	4		4		—
Total level 1	4		4		—
Level 2^{(2) (3)}
Commercial paper	618		410		208
Corporate bonds	27		—		27
Total level 2	645		410		235
Total	$	1,040	$	805	$	235


⁽¹⁾	The Company’s Level 1 assets are valued using quoted prices for identical instruments in active markets.


⁽²⁾	The Company did not have any transfers between Level 1 and Level 2 of the fair value hierarchy during the quarter and nine months ended September 26, 2015 or the year ended December 27, 2014.


⁽³⁾	The Company’s Level 2 short-term investments are valued using broker reports that utilize quoted market prices for identical or comparable instruments. Brokers gather observable inputs for all of the Company’s fixed income securities from a variety of industry data providers and other third-party sources.

Financial Instruments Not Recorded at Fair Value on a Recurring Basis



	September 26, 2015				December 27, 2014
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
	(In millions)
Short-term debt (excluding capital leases)	$	230	$	230	$	172	$	173
Long-term debt (excluding capital leases)	$	2,025	$	1,341	$	2,025	$	1,858

Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations



	Three Months Ended						Nine Months Ended
	September 26, 2015			September 27, 2014			September 26, 2015			September 27, 2014
	(In millions)
Foreign Currency Forward Contracts - gains (losses)
Contracts designated as cash flow hedging instruments
Other comprehensive income (loss)	$	(7	)	$	(2	)	$	(7	)	$	1
Cost of sales	(1		)	—			(2		)	—
Research and development	(3		)	—			(7		)	(2		)
Marketing, general and administrative	(2		)	(1		)	(5		)	$	(2	)
Contracts not designated as hedging instruments
Other income (expense), net	$	(2	)	$	(2	)	$	(3	)	$	(2	)

Schedule of Derivative Instruments in Balance Sheet



	September 26, 2015		December 27, 2014
	(In millions)
Interest Rate Swap Contracts - gains (losses)
Contracts designated as fair value hedging instruments	$	5	$	3



	September 26, 2015			December 27, 2014
	(In millions)
Foreign Currency Forward Contracts - gains (losses)
Contracts designated as cash flow hedging instruments	$	(13	)	$	(6	)
Contracts not designated as hedging instruments	$	(2	)	$	(1	)

- Definition

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

+ References + Details